Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans
Authors:
- Florent MorioFMFlorent Morio
- Fabrice PagniezFPFabrice Pagniez
- Myriam BesseMBMyriam Besse
- Françoise Gay-AndrieuFGFrançoise Gay-Andrieu
- Michel MiegevilleMMMichel Miegeville
- Patrice Le PapePatrice Le Pape
- 1 November 2013
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 42 (5) , 410-415
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Rare and emerging Candida speciesCurrent Fungal Infection Reports, 2009
- The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicansPLOS Pathogens, 2007
- Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans IsolatesEukaryotic Cell, 2007
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasisInternational Journal of Antimicrobial Agents, 2006
- A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicansGenetics, 2006
- TAC1 , Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2Eukaryotic Cell, 2004
- Role of Candida albicans Transcription Factor Upc2p in Drug Resistance and Sterol MetabolismEukaryotic Cell, 2004
- Application of Real-Time Quantitative PCR to Molecular Analysis of Candida albicans Strains Exhibiting Reduced Susceptibility to AzolesAntimicrobial Agents and Chemotherapy, 2004
- Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequencesThe Lancet Infectious Diseases, 2002